FlyteHealth

We’re a proud leader in tech-enabled medical care for people with obesity and comorbid health conditions. Today, we are rebranding as FlyteHealth for our customer and consumer-facing brand. “As our business in the care and navigation of the best-in-class obesity medicine program continues to grow, employers, payers and patients have come to know us as Flyte. With that increased visibility, we are consolidating under FlyteHealth as a single brand,” our CEO and co-founder Sloan Saunders explains. “This alignment allows us to continue to expand our offerings with our partners and provide a unified experience.” Powered by the patent-pending Flyte Intelligence platform, FlyteHealth delivers a user-friendly experience through the FlyteHealth app, care by a team of obesity medicine experts, and patient navigation services. The FlyteHealth approach is built upon the largest data set of obesity and chronic disease research available, as well as the decades of clinical experience of FlyteHealth’s founders — obesity medicine specialists who were among the first to see obesity not as a simple issue of willpower but as a complex disease that requires expert medical treatment. To learn more about our delivery of cost-effective care for obesity and related conditions, visit https://lnkd.in/gKdCZJwf.

Recent research highlights how GLP-1 receptor agonists not only help with weight loss but also provide protective benefits for kidney and cardiovascular health. As obesity is a complex condition, it's essential to recognize that a comprehensive approach — combining pharmacotherapy with lifestyle changes and medical supervision — can lead to the best outcomes for long-term weight management and overall well-being. Read more about the study: https://lnkd.in/diU93yvd

Obesity treatment is evolving, with a growing range of approaches, including GLP-1 medications like maridebart cafraglutide, also known as MariTide. In recent trials, MariTide helped patients lose up to 20% of their body weight without plateauing, positioning it as a strong contender in the anti-obesity medication space. However, as obesity is a complex and heterogeneous condition, it's important to recognize that no single treatment works for everyone. From lifestyle changes to medications, the best approach to managing obesity often involves a combination of therapies tailored to individual needs. Read more: https://lnkd.in/g-vSpba8

A recent study reveals that 25% of people on GLP-1 anti-obesity medications like Ozempic (semaglutide) report wasting more food compared to before starting the treatment. The research highlights how nausea from the medication and changing eating habits contribute to this increase, though adding vegetables to the diet was linked to reduced food waste. Understanding the effects of anti-obesity medications on individuals with obesity and overweight as they adjust to smaller portion sizes could improve overall treatment outcomes. Read more here: https://lnkd.in/gaZiRD6G

Katherine Saunders, MD, co-founder of FlyteHealth and a pioneer in obesity medicine, delivers a powerful TED Talk that’s redefining how we approach one of today’s most urgent health challenges. With expertise, empathy, and groundbreaking solutions, she sheds light on the path to effective obesity care and highlights how FlyteHealth is transforming access to treatment. Watch her talk and be inspired by the future of compassionate healthcare. Watch now: https://lnkd.in/gy5Zyurf TED Conferences

Emerging research highlights the intricate liver-brain connection in regulating eating patterns and underscores the complex biology of obesity. A new NIH-funded study reveals how disruptions in the liver's circadian clock—whether genetic or diet-induced—can alter eating behaviors and contribute to weight gain, offering insights into potential therapies. Understanding obesity as a multifaceted condition, not a matter of willpower, is key to advancing compassionate and effective care. Read more: https://lnkd.in/gSj8vQG8

Don’t miss this inspiring TED Talk by Katherine Saunders, MD, where she shares her expertise as a leader in obesity medicine and co-founder of FlyteHealth. With her groundbreaking insights and compassionate approach, Dr. Saunders is redefining how we treat one of the most pressing health challenges of our time and FlyteHealth is helping transform access to comprehensive obesity care. Watch here: https://lnkd.in/gy5Zyurf TED Conferences

Why does weight regain happen so often after dieting? A new study reveals that fat cells may retain a memory of previous weight gain through epigenetic changes. FlyteHealth co-founder and obesity medicine expert, Katherine Saunders, MD, shared that this groundbreaking research “might add to the growing body of evidence that disproves lack of willpower as the underlying force behind 'weight cycling.’” At FlyteHealth, we recognize the complexity of obesity as a chronic disease and are committed to evidence-based solutions that address its biological, environmental and behavioral factors. This study is a reminder of why compassionate, science-driven care is essential in supporting long-term weight management. Read more: https://lnkd.in/gaBADwmZ

A groundbreaking rule has been proposed to extend Medicare and Medicaid coverage for anti-obesity medications like semaglutide and tirzepatide for millions of Americans with obesity. If approved, this policy could transform obesity care while sparking debates on cost and health priorities. Read more: https://lnkd.in/gDvAqnV7

FlyteHealth co-founder, Katherine Saunders, MD, shares her incredible obesity medicine knowledge in her TED talk, now live and available to watch. 📽️ Watch the talk and get ready to be inspired: https://lnkd.in/gy5Zyurf TED Conferences